IRIS Accounts Production v25.1.3.33 06671167 Board of Directors 1.9.23 31.8.24 31.8.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh066711672023-08-31066711672024-08-31066711672023-09-012024-08-31066711672022-08-31066711672022-09-012023-08-31066711672023-08-3106671167ns14:PoundSterling2023-09-012024-08-3106671167ns10:Director12023-09-012024-08-3106671167ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3106671167ns10:SmallEntities2023-09-012024-08-3106671167ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3106671167ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3106671167ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3106671167ns10:FullAccounts2023-09-012024-08-3106671167ns10:OrdinaryShareClass12023-09-012024-08-3106671167ns10:Director22023-09-012024-08-3106671167ns10:CompanySecretary12023-09-012024-08-3106671167ns10:RegisteredOffice2023-09-012024-08-3106671167ns5:CurrentFinancialInstruments2024-08-3106671167ns5:CurrentFinancialInstruments2023-08-3106671167ns5:Non-currentFinancialInstruments2024-08-3106671167ns5:Non-currentFinancialInstruments2023-08-3106671167ns5:ShareCapital2024-08-3106671167ns5:ShareCapital2023-08-3106671167ns5:RetainedEarningsAccumulatedLosses2024-08-3106671167ns5:RetainedEarningsAccumulatedLosses2023-08-3106671167ns5:LeaseholdImprovements2023-09-012024-08-3106671167ns5:PlantMachinery2023-09-012024-08-3106671167ns5:FurnitureFittings2023-09-012024-08-3106671167ns5:LeaseholdImprovements2023-08-3106671167ns5:PlantMachinery2023-08-3106671167ns5:FurnitureFittings2023-08-3106671167ns5:LeaseholdImprovements2024-08-3106671167ns5:PlantMachinery2024-08-3106671167ns5:FurnitureFittings2024-08-3106671167ns5:LeaseholdImprovements2023-08-3106671167ns5:PlantMachinery2023-08-3106671167ns5:FurnitureFittings2023-08-3106671167ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3106671167ns5:WithinOneYearns5:CurrentFinancialInstruments2023-08-3106671167ns5:AcceleratedTaxDepreciationDeferredTax2024-08-3106671167ns5:AcceleratedTaxDepreciationDeferredTax2023-08-3106671167ns5:DeferredTaxation2023-08-3106671167ns5:DeferredTaxation2023-09-012024-08-3106671167ns5:DeferredTaxation2024-08-3106671167ns10:OrdinaryShareClass12024-08-3106671167ns5:RetainedEarningsAccumulatedLosses2023-08-3106671167ns5:RetainedEarningsAccumulatedLosses2023-09-012024-08-31
REGISTERED NUMBER: 06671167















SPECIALIST SKIN CLINIC LTD

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST AUGUST 2024






SPECIALIST SKIN CLINIC LTD (REGISTERED NUMBER: 06671167)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


SPECIALIST SKIN CLINIC LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST AUGUST 2024







DIRECTORS: Dr M L R Gonzalez
Mr D Zephir





SECRETARY: Mr D Zephir





REGISTERED OFFICE: 10 Penlline Road
Whitchurch
Cardiff
CF14 2AD





REGISTERED NUMBER: 06671167





ACCOUNTANTS: Carston ETL
Tudor House
16 Cathedral Road
Cardiff
CF11 9LJ

SPECIALIST SKIN CLINIC LTD (REGISTERED NUMBER: 06671167)

BALANCE SHEET
31ST AUGUST 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 464,674 330,536

CURRENT ASSETS
Stocks 5 53,081 7,681
Debtors 6 641,236 208,651
Cash at bank and in hand 733,256 954,837
1,427,573 1,171,169
CREDITORS
Amounts falling due within one year 7 333,428 181,624
NET CURRENT ASSETS 1,094,145 989,545
TOTAL ASSETS LESS CURRENT LIABILITIES 1,558,819 1,320,081

CREDITORS
Amounts falling due after more than one year 8 (242,636 ) (245,748 )

PROVISIONS FOR LIABILITIES 9 (108,987 ) (71,115 )
NET ASSETS 1,207,196 1,003,218

CAPITAL AND RESERVES
Called up share capital 10 100 100
Retained earnings 11 1,207,096 1,003,118
SHAREHOLDERS' FUNDS 1,207,196 1,003,218

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st August 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SPECIALIST SKIN CLINIC LTD (REGISTERED NUMBER: 06671167)

BALANCE SHEET - continued
31ST AUGUST 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28th May 2025 and were signed on its behalf by:





Dr M L R Gonzalez - Director


SPECIALIST SKIN CLINIC LTD (REGISTERED NUMBER: 06671167)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2024


1. STATUTORY INFORMATION

Specialist Skin Clinic Ltd is a private company, limited by shares , registered in Not specified/Other. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 10% straight line on cost
Plant and machinery - 20% straight line on cost
Fixtures and fittings - 20% straight line on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2023 - 4 ) .

SPECIALIST SKIN CLINIC LTD (REGISTERED NUMBER: 06671167)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST AUGUST 2024


4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and
property machinery fittings Totals
£    £    £    £   
COST
At 1st September 2023 - 1,080,882 10,000 1,090,882
Additions 31,920 153,103 56,573 241,596
At 31st August 2024 31,920 1,233,985 66,573 1,332,478
DEPRECIATION
At 1st September 2023 - 750,346 10,000 760,346
Charge for year 3,192 103,009 1,257 107,458
At 31st August 2024 3,192 853,355 11,257 867,804
NET BOOK VALUE
At 31st August 2024 28,728 380,630 55,316 464,674
At 31st August 2023 - 330,536 - 330,536

5. STOCKS
2024 2023
£    £   
Stocks 53,081 7,681

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Vidoria 546,871 109,000
Directors' current accounts 27,915 40,892
Accruals 56,127 49,518
Prepayments 10,323 9,241
641,236 208,651

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Hire purchase contracts 109,824 84,850
Trade creditors 82,346 -
Tax 133,769 91,561
PAYE and NIC taxes 1,091 1,281
Other creditors 158 50
Net Wages - 327
Pension Payable 2,700 755
Accruals and deferred income 3,540 2,800
333,428 181,624

SPECIALIST SKIN CLINIC LTD (REGISTERED NUMBER: 06671167)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST AUGUST 2024


8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Hire purchase contracts 242,636 245,748

9. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax
Accelerated capital allowances 108,987 71,115

Deferred
tax
£   
Balance at 1st September 2023 71,115
Provided during year 37,872
Balance at 31st August 2024 108,987

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary 1 100 100

11. RESERVES
Retained
earnings
£   

At 1st September 2023 1,003,118
Profit for the year 335,978
Dividends (132,000 )
At 31st August 2024 1,207,096